Atlas Trials

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

Clinical trial NCT06917872 · COMPLETED

Trial details

NCT number
NCT06917872
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2025-04-29
Primary completion
2025-09-09
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.